Skip to main content
. 2020 Oct 19;20:74. doi: 10.1186/s40644-020-00356-5

Fig. 4.

Fig. 4

Comparison of metastatic recurrence-free survival rates between 18F-fluorodeoxyglucose positron emission tomography positive and negative groups. Metastatic recurrence-free survival was significantly shorter in the 18F-fluorodeoxyglucose positron emission tomography positive uptake group than in the negative group (p < 0.001)